NO901533L - Aminosyrederivater. - Google Patents

Aminosyrederivater.

Info

Publication number
NO901533L
NO901533L NO90901533A NO901533A NO901533L NO 901533 L NO901533 L NO 901533L NO 90901533 A NO90901533 A NO 90901533A NO 901533 A NO901533 A NO 901533A NO 901533 L NO901533 L NO 901533L
Authority
NO
Norway
Prior art keywords
amino acid
acid derivative
derivative
amino
acid
Prior art date
Application number
NO90901533A
Other languages
English (en)
Other versions
NO901533D0 (no
Inventor
Quirico Branca
Hans Peter Maerki
Werner Neidhart
Henri Ramuz
Wolfgang Wostl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO901533D0 publication Critical patent/NO901533D0/no
Publication of NO901533L publication Critical patent/NO901533L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO90901533A 1989-04-05 1990-04-04 Aminosyrederivater. NO901533L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH129089 1989-04-05

Publications (2)

Publication Number Publication Date
NO901533D0 NO901533D0 (no) 1990-04-04
NO901533L true NO901533L (no) 1990-10-08

Family

ID=4206973

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90901533A NO901533L (no) 1989-04-05 1990-04-04 Aminosyrederivater.

Country Status (15)

Country Link
US (1) US5140011A (no)
EP (1) EP0391179A3 (no)
JP (1) JPH02290836A (no)
KR (1) KR900016114A (no)
AU (1) AU5252290A (no)
CA (1) CA2012901A1 (no)
FI (1) FI901730A7 (no)
HU (1) HUT53598A (no)
IL (1) IL93955A0 (no)
MC (1) MC2107A1 (no)
NO (1) NO901533L (no)
NZ (1) NZ233082A (no)
PT (1) PT93658A (no)
YU (1) YU65690A (no)
ZA (1) ZA902444B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US5250517A (en) * 1987-10-06 1993-10-05 Hoffmann-La Roche Inc. Renin inhibiting compounds
CA1328333C (en) * 1988-03-04 1994-04-05 Quirico Branca Amino acid derivatives
US5430041A (en) * 1991-05-10 1995-07-04 Hoffmann-La Roche Inc. Amino acid derivatives having antiviral activity
US7141609B2 (en) 1992-08-25 2006-11-28 G.D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
DE122007000045I2 (de) * 1992-08-25 2011-07-21 Gd Searle Llc Gd Searle Llc Darunavir oder pharmazeutisch vertragliche Salze, Hydroxyethylaminosulfonamide verwendbar als InhibiEster oder Prodrugs davon. toren retroviraler Proteasen.
US5326773A (en) * 1992-10-29 1994-07-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
AU1596895A (en) * 1994-01-25 1995-08-08 G.D. Searle & Co. Malarial aspartic protease inhibitors
US5777153A (en) * 1994-07-08 1998-07-07 Gilead Sciences, Inc. Cationic lipids
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
EP1095022A1 (en) 1998-07-08 2001-05-02 G.D. Searle & Co. Retroviral protease inhibitors
JP2008266292A (ja) * 2007-03-23 2008-11-06 Sumitomo Chemical Co Ltd ベンゾアゾール化合物の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8322414D0 (en) * 1983-08-19 1983-09-21 Szelke M Renin inhibitors
US4613676A (en) * 1983-11-23 1986-09-23 Ciba-Geigy Corporation Substituted 5-amino-4-hydroxyvaleryl derivatives
US4652551A (en) * 1984-06-22 1987-03-24 Abbott Laboratories Renin inhibiting compounds
US4880781A (en) * 1984-08-06 1989-11-14 The Upjohn Company Renin inhibitory peptides containing an N-alkyl-histidine moiety
US4727060A (en) * 1984-11-13 1988-02-23 Ciba-Geigy Corporation Novel 5-amino-4-hydroxyvaleryl derivatives
IL81234A (en) * 1986-01-16 1992-09-06 Abbott Lab Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them
EP0264106B1 (en) * 1986-10-14 1994-03-16 Banyu Pharmaceutical Co., Ltd. 5-Substituted amino-4-hydroxy-pentanoic acid derivatives and their use
US4758584A (en) * 1987-02-05 1988-07-19 Ciba-Geigy Corporation Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by sulphur-containing groups
DK523288A (da) * 1987-10-06 1989-04-07 Hoffmann La Roche Aminosyrederivater

Also Published As

Publication number Publication date
US5140011A (en) 1992-08-18
KR900016114A (ko) 1990-11-12
ZA902444B (en) 1990-12-28
NZ233082A (en) 1992-11-25
EP0391179A2 (de) 1990-10-10
EP0391179A3 (de) 1991-04-03
AU5252290A (en) 1990-11-22
HUT53598A (en) 1990-11-28
CA2012901A1 (en) 1990-10-05
MC2107A1 (fr) 1991-03-11
PT93658A (pt) 1990-11-20
NO901533D0 (no) 1990-04-04
YU65690A (en) 1991-10-31
FI901730A7 (fi) 1990-10-06
IL93955A0 (en) 1990-12-23
JPH02290836A (ja) 1990-11-30
FI901730A0 (fi) 1990-04-05
HU902037D0 (en) 1990-08-28

Similar Documents

Publication Publication Date Title
NO901399L (no) Aminosyrederivater.
FI905983L (fi) Aminosyraderivat.
NO892407L (no) Aminosyrederivater.
NO903832D0 (no) Aminosyrederivater.
NO901033L (no) Aminosyrederivater.
DE59008394D1 (de) Aminosäureamid-Derivate.
FI891006A7 (fi) Aminosyraderivat.
FI920420A7 (fi) Aminosyraderivat.
FI913236L (fi) 9-purinylfosfonsyraderivat.
DE122005000012I1 (de) N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl)-Glutamins{urederivate.
NO884434D0 (no) Aminosyrederivater.
DE3787657D1 (de) Aminosäure-Derivate.
NO901533D0 (no) Aminosyrederivater.
FI892362L (fi) Buten- eller propensyraderivat.
FI900024A7 (fi) Pyrrolylfenyl-substituerade hydroxamsyraderivat.
NO912537L (no) Aminosyrederivater.
NO890635L (no) Reninhemmende aminosyrederivater.
FI891761L (fi) Aminosyraderivat.
FI906104L (fi) Naftylsulfonylalkansyraderivat.
DE69018816D1 (de) Aminosäurederivate.
NO901519D0 (no) Aminosyrederivater.
DE59002430D1 (de) Cyclopropanoylaminosäureamid-Derivate.
FI925068L (fi) Aminosyraderivat
ATE105549T1 (de) Aminosaeure-derivate.
ATE95518T1 (de) Aminosaeure-derivate.